ERBB2 and breast cancer: In breast cancer cells, transfection of HER2 into MCF7 cells caused PI3K-dependent activation of Akt, resulting in increased resistance to several chemotherapy drugs, including paclitaxel, doxorubicin, 5-fluorouracil, etoposide, and camptothecin.